Skip to main content
Clinical Trials/JPRN-UMIN000028754
JPRN-UMIN000028754
Not yet recruiting
未知

Silent cerebral microvascular disease and longitudinal risK of cognitive decline in Atrial Fibrillation study - SKAF Study

DAIICHI SANKYO COMPANY0 sites200 target enrollmentOctober 1, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
on-valvular atrial fibrillation
Sponsor
DAIICHI SANKYO COMPANY
Enrollment
200
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 1, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
DAIICHI SANKYO COMPANY

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\)The patient who participates in an intervention examination now or plans it (2\)The patient who is given a definitive diagnosis of mitral stenosis (3\)he patient who has an Artificial valve (aMachine valve or a Bioprosthetic valv) (4\)The patient who received art of heart intervention 1 month before enrolled (5\)The patient who contraindications of MRI inspection (6\)The patient who has a depression (7\)The patient who is remaining 2 years because of some diseases (8\)The patient who is inappropriateness of this study judged by the doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials